Biopharmas raising money in public or private financings, including: Ambrosia Biosciences, Kymera, Photonpharma, Revelation Biosciences.

Med-tech firms raising money in public or private financings, including: Eyenovia, Work Medical Technology Group.

With biopharma IPO volume at a 10-year low, two companies are bucking the trend with plans to plunge into the public market. Bifunctional antibody drug developers Bicara Therapeutics Inc. and Zenas Biopharma Inc. have filed with the SEC to go public though neither has named share-price ranges.

Biopharmas raising money in public or private financings, including: Pharmazz, Sun Pharmaceutical, Retention, Reviva, Scinai.

Med-tech firms raising money in public or private financings, including: Beme Health.

After sparking further interest from investors after the close of its series A, Vandria SA has extended the round and now has the means to advance its lead mitophagy inducer program as far as phase Ib/IIa development in the treatment of mild cognitive impairment.

Biopharmas raising money in public or private financings, including: Algernon, Geovax, Kymera, Pathalys, Scorpius, Sernova.

Med-tech firms raising money in public or private financings, including: Cairn Surgical, Eyenovia, Precisedx, XII Medical.